openPR Logo
Press release

Investigation announced for Investors in Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX)

11-18-2021 05:01 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares over potential wrongdoing at Kiora Ph

An investigation on behalf of investors in Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares over potential wrongdoing at Kiora Ph

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kiora Pharmaceuticals, Inc f.k.a EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG).

Investors who purchased shares of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Kiora Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders.

Waltham, MA based Kiora Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Kiora Pharmaceuticals, Inc. reported that its annual Total Revenue declined from $2.68 million in 2019 to $0.012 million in 2020, and that its Net Loss increased from $7.09 million in 2019 to $8.17 million in 2020.

Shares of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) declined from over $12 per share in late 2019 to as low as $1.44 per share in August 2021.

On November 17, 2021, NASDAQ: KPRX shares closed at $1.50 per share.

Those who purchased shares of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) here

News-ID: 2465974 • Views: 595

More Releases from Shareholders Foundation

Investigation for Long-Term Investors in shares of Camber Energy, Inc. (NYSE: CE …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Camber Energy, Inc.. Investors who are current long term investors in Camber Energy, Inc. (NYSE: CEI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: CEI stocks follows a lawsuit filed against Camber
Investigation announced for Investors in ReneSola Ltd (NYSE: SOL) over potential …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at ReneSola Ltd. Investors who purchased shares of ReneSola Ltd (NYSE: SOL) and currently hold any of those NYSE: SOL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain ReneSola Ltd directors breached their fiduciary duties and caused damage
Investigation announced for Investors in shares of Fennec Pharmaceuticals Inc. ( …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Fennec Pharmaceuticals Inc. Investors who purchased shares of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Fennec Pharmaceuticals directors breached their fiduciary duties and caused damage to the company and its shareholders. North Carolina
Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ: KPRX) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. Investors who purchased shares of Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. (NASDAQ: KPRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Kiora Pharmaceuticals, Inc. f.k.a. EyeGate Pharmaceuticals, Inc. officers and

All 5 Releases